The new face of cardiac care in India: KardiaMobile by AliveCor

Cardiac care in India is getting an upgrade with the launch of AliveCor. AliveCor empowers people worldwide to proactively manage their heart health and improve the quality of care in the fight against heart disease. Recognized as a 2015 Tech Pioneer by the World Economic Forum, and one of the 50 Smartest Companies by the MIT Technology Review (#14), AliveCor is now bringing its smart ECG solutions to India, using advanced artificial intelligence, cloud, and micro-electrode technology for cardiac care. The KardiaMobile products enable patients and doctors to easily, quickly and inexpensively detect and manage possible abnormal heart rhythms, anytime, anywhere.

AliveCor’s KardiaMobile:

FDA-cleared KardiaMobile is the most clinically validated mobile electrocardiogram (ECG) solution on the market. It is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. The newer, and more advanced, KardiaMobile 6L is the world’s first FDA-cleared, six-lead personal heart monitoring device. This unique, smartphone-based technology provides a multi-dimensional view of the heart in 30-seconds, including visibility into the leading arrhythmias, such as atrial fibrillation (AF), that are leading indicators of cardiovascular disease. By providing physicians with six different views of the electrical activity of the heart, KardiaMobile 6L offers a much greater chance of detecting a broad range of arrhythmias and other heart conditions than a single lead device.

Once a recording has been taken, the artificial intelligence system performs an automatic analysis and informs the patient whether atrial fibrillation, bradycardia (slow heart rhythm), tachycardia (fast heart rhythm) or a normal rhythm is detected. The data collected can then be sent directly to a doctor for further analysis and consultation. Kardia is the first A.I. enabled platform to help clinicians manage patients for the early detection of atrial fibrillation, which is the most common cardiac arrhythmia and one that leads to a five times greater risk of stroke. 

AliveCor’s deep neural network assesses heart rate data, as well as physical activity and other influencing factors, to notify users of possible irregularities in their heart rhythm. Eventually, AliveCor’s analysis of biometric data will work to understand a range of serious heart conditions and even changes in blood chemistry. The use of artificial intelligence will help add meaning to patient data, and facilitate important improvements in insights, therapies, and procedures.

Coming Alive – How it all began

While AliveCor and its life-saving products are in the limelight now, the company goes back many years. Founder of AliveCor, Dr. David Albert, MD, along with co-founders Bruce Satchwell and Kim Barnett had been working on wireless ECG technology for nearly 15 years. Dr. Albert came into mainstream media attention in 2010, when a video of him demonstrating a prototype of an iPhone electrocardiogram device went viral. It was a prototype he had been working on in his spare time, and was to present it at a Consumer Electronics Show.  Dr. Albert uploaded a video on YouTube and within days it was viewed over 100,000 times. Soon after, the tech giant, Apple Inc. took note, and invited him to their headquarters to explain how the technology works. This path-breaking technology got the attention of the FDA and in 2014, was granted the company clearance for its algorithm to detect atrial fibrillation (AFib), the most common form of cardiac arrhythmia.

AliveCor’s automated analysis process would instantly detect atrial fibrillation through the real-time ECG recordings so that physicians could intervene before potentially life-threatening conditions, like strokes, occur. “We believe that mobile ECGs and other breakthroughs in mobile health can significantly change the way medicine is delivered,” Dr. Albert said in a press release. 

Personalized Heart Care now in India

AliveCor is now coming to India, with path-breaking technology that has transformed lives around the world. The ability to detect serious heart arrhythmia using mobile technology has the potential to save lives, reduce healthcare costs and allow patients and doctors to make informed decisions about cardiac care. You can keep your family’s heart health in check from the comfort of your home. For more information, please visit, and check our products Kardia Mobile 6L & Kardia Mobile

For more updates and exclusive information on being heart-healthy, follow us on Facebook, Twitter, Instagram and LinkedIn.